Assignee
CIPLA LTD
IN·122 granted patents·103 pending applications·386 citations·filing 2001–2024
Top patents by PatentIndex Score
225 records- 0195US9901585B2Combination of azelastine and fluticasone for nasal administrationCIPLA LTD·Filed 2016·Granted Feb 27, 2018·12 cites·30 claims
- 0292US9913853B2Stabilized liquid fosaprepitant formulationsCIPLA LTD·Filed 2016·Granted Mar 13, 2018·7 cites·22 claims
- 0392USD590495SMultidose inhalerCIPLA LTD·Filed 2007·Granted Apr 14, 2009·48 cites·1 claims
- 0490US10098890B2Stable carfilzomib formulationsCIPLA LTD·Filed 2017·Granted Oct 16, 2018·7 cites·21 claims
- 0590US9227990B2Antiviral phosphonate analogues and process for preparation thereofCIPLA LTD·Filed 2013·Granted Jan 5, 2016·14 cites·16 claims
- 0690US7638627B2Process of preparing imatinib and imatinib prepared therebyCIPLA LTD·Filed 2004·Granted Dec 29, 2009·22 cites·32 claims
- 0790USD590938SMultidose inhalerCIPLA LTD·Filed 2008·Granted Apr 21, 2009·43 cites·1 claims
- 0889US10301282B2Polymorphic form X of nilotinib dihydrochloride hydrateCIPLA LTD·Filed 2016·Granted May 28, 2019·6 cites·15 claims
- 0987US11077124B2Pharmaceutical compositionsCIPLA LTD·Filed 2017·Granted Aug 3, 2021·2 cites·22 claims
- 1087US10912734B2Depot formulationCIPLA LTD·Filed 2019·Granted Feb 9, 2021·2 cites·17 claims
- 1186US10940274B2Nasal spray assemblyCIPLA LTD·Filed 2016·Granted Mar 9, 2021·9 cites·18 claims
- 1286US10328153B2Rifaximin complexesCIPLA LTD·Filed 2018·Granted Jun 25, 2019·3 cites·20 claims
- 1385US10307432B2Stabilized liquid fosaprepitant formulationsCIPLA LTD·Filed 2018·Granted Jun 4, 2019·2 cites·21 claims
- 1484US6995286B2Process for preparing isomers of salbutamolCIPLA LTD·Filed 2001·Granted Feb 7, 2006·11 cites·8 claims
- 1583US12109200B2RifaximinCIPLA LTD·Filed 2022·Granted Oct 8, 2024·0 cites·4 claims
- 1683US12109270B2Rifaximin complexesCIPLA LTD·Filed 2022·Granted Oct 8, 2024·0 cites·12 claims
- 1783US9259428B2Combination of azelastine and fluticasone for nasal administrationCIPLA LTD·Filed 2015·Granted Feb 16, 2016·2 cites·30 claims
- 1882US11234981B2Combination therapy for use in treating retroviral infectionsCIPLA LTD·Filed 2018·Granted Feb 1, 2022·1 cites·23 claims
- 1982US9993561B2Rifaximin complexesCIPLA LTD·Filed 2014·Granted Jun 12, 2018·3 cites·22 claims
- 2082US9993560B2Rifaximin complexesCIPLA LTD·Filed 2014·Granted Jun 12, 2018·3 cites·26 claims
- 2181US10709715B2Method of treating hypertensionCIPLA LTD·Filed 2018·Granted Jul 14, 2020·1 cites·21 claims
- 2280US10391080B2Ketorolac for the treatment of cancerCIPLA LTD·Filed 2017·Granted Aug 27, 2019·1 cites·15 claims
- 2380US10149848B2Method for the treatment of bladder cancerCIPLA LTD·Filed 2016·Granted Dec 11, 2018·1 cites·12 claims
- 2480US9867865B1Mesalamine for the treatment of cancerCIPLA LTD·Filed 2017·Granted Jan 16, 2018·1 cites·17 claims
- 2580US9763901B2Treatment of hepatitis C using histone deacetylase inhibitorsCIPLA LTD·Filed 2016·Granted Sep 19, 2017·1 cites·6 claims
- 2680US8937057B2Combination of azelastine and mometasone for nasal administrationCIPLA LTD·Filed 2012·Granted Jan 20, 2015·2 cites·30 claims
- 2780US8933060B2Combination of azelastine and ciclesonide for nasal administrationCIPLA LTD·Filed 2012·Granted Jan 13, 2015·2 cites·26 claims
- 2879US10966982B2Stable pharmaceutical formulations of pemetrexedCIPLA LTD·Filed 2019·Granted Apr 6, 2021·2 cites·24 claims
- 2979US7989636B2Process for the preparation of pure anastrozoleCIPLA LTD·Filed 2007·Granted Aug 2, 2011·2 cites·29 claims
- 3079US7285669B2Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazoleCIPLA LTD·Filed 2003·Granted Oct 23, 2007·8 cites·18 claims
- 3178US2024285629A1Combination Therapy for Use in Treating Retroviral InfectionsCIPLA LTD·Filed 2024·Application pending·0 cites
- 3277US7973173B2Process for the synthesis of an ACE inhibitorCIPLA LTD·Filed 2006·Granted Jul 5, 2011·3 cites·14 claims
- 3377US2024016814A1Method of treating hypertensionCIPLA LTD·Filed 2023·Application pending·0 cites
- 3476US9446054B2Pharmaceutical products and composition comprising specific anticholinergic agents, β-2 agonists and corticosteroidsCIPLA LTD·Filed 2014·Granted Sep 20, 2016·2 cites·10 claims
- 3576US7892483B2Sterilization processCIPLA LTD·Filed 2005·Granted Feb 22, 2011·3 cites·22 claims
- 3675US12472190B2Pharmaceutical compositionsCIPLA LTD·Filed 2021·Granted Nov 18, 2025·0 cites·19 claims
- 3775US2020147225A1Rifaximin complexesCIPLA LTD·Filed 2019·Application pending·0 cites
- 3874US7666896B2Process for the preparation of perindoprilCIPLA LTD·Filed 2005·Granted Feb 23, 2010·1 cites·19 claims
- 3974US7470789B2Fexofenadine polymorphs and processes of preparing the sameCIPLA LTD·Filed 2004·Granted Dec 30, 2008·6 cites·16 claims
- 4073US11129836B2PAR-4 agonists for the treatment of cancerCIPLA LTD·Filed 2019·Granted Sep 28, 2021·0 cites·8 claims
- 4173US8006695B2InhalerCIPLA LTD·Filed 2005·Granted Aug 30, 2011·12 cites·41 claims
- 4273US7112577B2Pharmaceutically acceptable alendronate salts in amorphous formCIPLA LTD·Filed 2002·Granted Sep 26, 2006·6 cites·14 claims
- 4372US12090163B2Pharmaceutical compositionsCIPLA LTD·Filed 2018·Granted Sep 17, 2024·1 cites·20 claims
- 4472US7579505B2Crystalline levosalbutamol sulphate and polymorphic forms thereofCIPLA LTD·Filed 2005·Granted Aug 25, 2009·2 cites·12 claims
- 4571US7538249B2Tolterodine, compositions and uses thereof, and preparation of the sameCIPLA LTD·Filed 2004·Granted May 26, 2009·4 cites·24 claims
- 4670US8003804B2Synthesis of 4-[1-(4-cyano phenyl)-(1,2,4-triazol-1-yl)methyl] benzonitrile and 4-[1-(1H-1,2,4-triazol-1-yl)methylene benzonitrile intermediateCIPLA LTD·Filed 2007·Granted Aug 23, 2011·1 cites·3 claims
- 4770US7550593B2Process for the preparation of finasteride Form ICIPLA LTD·Filed 2004·Granted Jun 23, 2009·1 cites·8 claims
- 4870US2021401851A1Par-4 agonists for the treatment of cancerCIPLA LTD·Filed 2021·Application pending·0 cites
- 4970US2023030113A1Method of treating hypertensionCIPLA LTD·Filed 2022·Application pending·0 cites
- 5070US2023119206A1Compositions comprising ibrutinib and an alkaloid having enhanced bioavailabilityCIPLA LTD·Filed 2022·Application pending·0 cites
Showing the top 50 of 225 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →